Page 95 - Read Online
P. 95

Rivera. Neuroimmunol Neuroinflammation 2018;5:12              Neuroimmunology and
               DOI: 10.20517/2347-8659.2018.16                                   Neuroinflammation




               Commentary                                                                    Open Access


               Multiple sclerosis: depression and disability are
               globally shared issues of concern

               Victor M. Rivera

               Department of Neurology, Baylor College of Medicine, Houston, TX 77025, USA.

               Correspondence to: Dr. Victor M. Rivera, Department of Neurology, Baylor College of Medicine, Cambridge Street 7200, 9th Floor,
               Houston, TX 77025, USA. E-mail: vrivera@bcm.edu

               How to cite this article: Rivera VM. Multiple sclerosis: depression and disability are globally shared issues of concern.
               Neuroimmunol Neuroinflammation 2018;5:12. http://dx.doi.org/10.20517/2347-8659.2018.16

               Received: 30 Mar 2018    Accepted: 31 Mar 2018      Published: 18 Apr 2018
               Science Editor: Athanassios P. Kyritsis    Copy Editor: Guang-Zhe Zhu    Production Editor: Huan-Liang Wu



               While multiple sclerosis (MS) is more common among Caucasian populations, its prevalence is increasingly
               noted in ethnic groups that had previously been considered to have a low frequency of the disease.
               Epidemiologic studies indicate a considerable augmentation of MS presence in areas such the Middle
                                              [2]
                   [1]
               East  and Latin American countries . Along with the general clinical effects of this complex neurological
               disorder is the impact exerted by some of its comorbid neuropsychiatric manifestations particularly
                                                                                               [3]
               depression, described as affecting three times higher MS patients than the general population . Literature
               and general perceptions had suggested clinical depression, although chronic in most MS cases, was
                                                           [4,5]
               unrelated to disability progression or disease course .

                                  [6]
               A Saudi Arabia study  published in Neuroimmunology and Neuroinflammation, acquired data from all
               geographic regions of the Kingdom involving 598 MS patients, and finding that 97.7% had some degrees
               of depression as assessed with the patient health questionnaire, a reliable and valid measure of depression
               severity. In this study, most had mild-to-moderate depression. The Saudi Arabian investigators correlated
               these data with scores obtained from disability quantified with the patient determined disease steps which
               has a strong correlation with the scores derived from the expanded disability status scale, the cardinal
               marker of neurological disability in MS. There was a significant association between patients’ level of
               neurological disability and severity of depression (P < 0.001). Interestingly, none of the patients reported
               absence of depression had a moderate or severe disability while those with moderately severe or severe
               depression had the highest percentages of severe disability. Aspects that escaped the authors explanation
               was the fact that severe depression was more prominent in patients residing in the northern areas of the
               country and that 13% of the subjects were foreigners, their country origin was not reported. Saudi Arabia
                                                            [7]
               has a medium to high MS prevalence (≥ 40/100,000)  has substantial immigrant population from nearby

                           © The Author(s) 2018. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
                sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long
                as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
                and indicate if changes were made.


                                                                                                                                                      www.nnjournal.net
   90   91   92   93   94   95   96   97   98   99   100